Results 251 to 260 of about 5,563,712 (386)

Integration of Methamphetamine Harm Reduction into Opioid Harm Reduction Services in Iran: Preliminary Results of a Pilot Study

, 2017
Seyed Ramin Radfar, Setareh Mohsenifar, Alireza Noroozi   +2 more
openalex   +1 more source

Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine

, 2022
Daniel Arendt
openalex   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community. [PDF]

Harm Reduct J
Kruger DJ, Mersereau G, Sullivan A, Barron J, Herberholz M, Pouyan N, Aday JS, Boehnke KF.   +7 more
europepmc   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Evaluation of a "one-stop shop" for integrated harm reduction and primary care for people who inject drugs. [PDF]

PLoS One
Ibrahim N, Jones S, Rich K, Alvarez L, Price C, Kil N, Altice FL, Meyer JP.   +7 more
europepmc   +1 more source

Patterns of Relations Between Adverse Childhood Experiences, Risk-taking Behaviors, and the Influence of Protective Factors on Harm Reduction and Resilience In a University Student Sample Survey

, 2020
Hope Parker
openalex   +1 more source

Harm reduction workforce, behavioral health, and service delivery in the USA: a cross-sectional study [PDF]

Lisa de Saxe Zerden, Orrin D. Ware, Brooke N. Lombardi, Brianna M. Lombardi   +3 more
openalex   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Co-creating harm reduction resources with young people who use nitrous oxide: What catches their attention? [PDF]

Harm Reduct J
Kor K, Allan J, Cameron J, Simpson H.
europepmc   +1 more source